Padda et al. also demonstrated that the majority of prostate-specific membrane antigen (PSMA) expressing EVs in plasma of prostate cancer patients derive directly from the plasma membrane and have a larger size [14]; hence, these clinically important populations are missed by solely the exosome analysis. The gene discussed is FOLH1; the disease is Familial prostate cancer.